MedDataX Logo

Study of Elderly Patients With Cancer and Seen in Consultation of Geriatric Oncology in the Nord Pas-de-Calais (CONSOG).

NCT ID: NCT02501174

Last Updated: 2021-10-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

2914 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-10-31

Study Completion Date

2019-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to establish a common geriatric oncology medical database. The patients concerned are the patients having benefited from a geriatric oncology consultation in one of the participating centres. This database is designed with a view on the one hand to better describe to better understand this population and on the other hand to facilitate the conduct of future retrospective or prospective studies on this population. The constitution of this observatory of patients seen in consultation should facilitate the development of studies from the analysis of data collected, and occasional surveys by the rapid identification of cases. Data from this database could provide clinicians with valuable informative elements of descriptive epidemiology and concerning the organization of care in the geriatric oncology field.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study is presented during the first consultation of oncogeriatric care or after this consultation (for patients having benefited from the consultation between January 2014 and October 2014) : the patient is informed with an information note and is told that he can express its opposition to the use of its clinical data. In case of no opposition from the patient, the referent geriatrician will complete the patient form with the requested data and will forward it for computerized processing.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient seen in consultation of geriatric oncology in one of the participating centres in Nord Pas-de-Calais.
* Age ≥ 65 years
* Patient having been informed and not opposing the computerized processing of its data.

Exclusion Criteria

* Patient having opposed the use of its medical data.
Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Oscar Lambret

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Cédric GAXATTE, MD

Role: PRINCIPAL_INVESTIGATOR

CHRU de Lille

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre Hospitalier d'Arras

Arras, , France

Site Status

Centre Hospitalier

Béthune, , France

Site Status

Centre Hospitalier

Boulogne-sur-Mer, , France

Site Status

Centre Hospitalier, Douai

Douai, , France

Site Status

Centre Hospitalier

Dunkirk, , France

Site Status

Hospitalier Le Cateau-Cambresis

Le Cateau-Cambrésis, , France

Site Status

Polyclinique de Riaumont

Liévin, , France

Site Status

CHRU de Lille

Lille, , France

Site Status

Hôpital Saint Vincent de Paul

Lille, , France

Site Status

Centre Oscar Lambret

Lille, , France

Site Status

Hôpital Saint-Philibert

Lomme, , France

Site Status

Clinique Saint Jean, Roubaix

Roubaix, , France

Site Status

Centre Hospitalier

Tourcoing, , France

Site Status

Centre de cancérologie Les Dentellières

Valenciennes, , France

Site Status

Centre Hospitalier

Valenciennes, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CONSOG-1401

Identifier Type: -

Identifier Source: org_study_id